Cybin (HELP) Depreciation and Depletion (2020 - 2023)
Cybin's (HELP) quarterly Depreciation and Depletion came in at -$56037.0 in Q1 2023, down 1051.88% YoY from $5887.0 in Q1 2022, and down 1352.5% on a QoQ basis from $4474.0 in Q2 2022.
Cybin (HELP) Depreciation and Depletion (2020 - 2023) Analysis & Trends
Cybin (HELP) has 4 years of Depreciation and Depletion data on file, last reported at -$56037.0 in Q1 2023.
- Quarterly Depreciation and Depletion fell 1051.88% year-over-year to -$56037.0 in Q1 2023, while the trailing twelve-month figure through Feb 2023 was -$10769.2 (down 110.25% YoY) and the FY2023 annual result came in at $36915.1, up 125.73% from the prior year.
- Depreciation and Depletion slipped to -$56037.0 in Q1 2023, from $4474.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $34906.8 in Q4 2021 to a low of -$56037.0 in Q1 2023.
- A 4-year average of $9068.8 and a median of $9971.7 in 2020 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2021 — Depreciation and Depletion surged 250.06% — and 2023, when it slumped 1051.88%.
- Tracing HELP's Depreciation and Depletion over 4 years: stood at $9971.7 in 2020, then surged by 250.06% to $34906.8 in 2021, then sank by 87.18% to $4474.0 in 2022, then plunged by 1352.5% to -$56037.0 in 2023.
- The last three Depreciation and Depletion figures came in at -$56037.0 (Q1 2023), $4474.0 (Q2 2022), and $5887.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2023 | -56,036.99 |
| Feb 28, 2023 | -56,036.99 |
| May 31, 2022 | 4,474.02 |
| May 31, 2022 | 4,474.02 |
| Feb 28, 2022 | 5,886.99 |
| Feb 28, 2022 | 5,886.99 |
| Dec 31, 2021 | 34,906.79 |
| Dec 31, 2021 | 34,906.79 |
| Sep 30, 2021 | 33,365.19 |
| Sep 30, 2021 | 33,365.19 |
| Jun 30, 2021 | 30,914.03 |
| Jun 30, 2021 | 30,914.03 |
| Dec 31, 2020 | 9,971.71 |
| Dec 31, 2020 | 9,971.71 |